MAPK3 and breast carcinoma: Combined with RNA-seq analysis, we found that CXCL1-3 and CXCL8 are highly expressed in co-cultured breast cancer cells, and CXCR2 is the critical receptor to activate the ERK1/2 signaling pathway in CAAs.